← brief for 2026-10-24 · People & money

Highlights from ASCO 2026: focus on immuno-oncology in kidney cancer

Article No results yet Peer reviewed

Key takeaways

This article summarizes new cancer drug data from a 2026 medical meeting. It focuses on immune therapy for kidney cancer. There are no new trial results in this piece.

Who did this work

Sonia Vallet (Karl Landsteiner University of Health Sciences)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-23
https://doi.org/10.1007/s12254-026-01134-y